NASDAQ:CORT

Corcept Therapeutics Incorporated Earning Date

USA |NASDAQ |USD

CORT Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 1, 2021 Sep 2021 $0.20 $0.21 $0.17
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 1, 2021 Sep 2021 $97.65M $91.59M $86.33M

Corcept Therapeutics Incorporated's next earnings date is Monday, Nov 1, 2021 for the fiscal quarter ending Sep 2021.

CORT Earnings Date & History Chart

CORT Earnings & Revenue Forecast

CORT Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $0.22 $0.21 $0.23
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $0.82 $0.77 $0.88
Dec 2022 3 $0.98 $0.92 $1.03

CORT Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $0.22 $0.22 $0.25
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $0.82 $0.82 $0.82
Dec 2022 0 / 0 $0.98 $0.98 $1.02

CORT Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $104.01M $100.30M $108.00M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $372.67M $368.40M $377.00M
Dec 2022 4 $427.62M $409.80M $440.80M

CORT Earnings Date & Revenue History

CORT Earnings History

|
Show More
Show More

CORT Revenue History

|
Show More
Show More

Corcept Therapeutics Incorporated Next Earnings Date & Report

CORT Next Earnings Date & Report Preview: Sep 2021 (FQ)

CORT's next earnings date is Monday, Nov 1, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 4 analysts, the average EPS estimation for Corcept Therapeutics Incorporated's next quarterly earnings is $0.20, with a low EPS estimation of $0.18, and a high estimation of $0.22.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $0.20, the last 2 month trend is $0.20, and the 3 month trend is $0.22.

Based on 4 analysts, the average revenue estimation is $97.65M, with a low revenue estimation of $97.10M, and a high estimation of $98.00M.

Corcept Therapeutics Incorporated Previous Earnings Dates & Reports

CORT Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Corcept Therapeutics Incorporated's previous earnings date was Jul 29, 2021 for its fiscal quarter ended Jun 30, 2021.

CORT's earnings per share (EPS) was $0.21, beating the consensus analysts forecast of $0.16 by 33.33%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by 16.67%, and lower than the same period a year before (Jun 2020) by -8.70%.

Revenues were $91.59M, better than the forecast of $91.59M by 0.00%, up by 15.30% from the previous quarter , and up by 3.41% from the same period last year.

The company reported a net income of $26.52M, 13.03% higher than the previous quarter, and lower by -6.37% than the same period a year before.

Free cash flow for the quarter was $44.22M , compared to $25.30M last quarter and $53.14M a year before.

CORT ended the quarter with $1.56M in total debt, a decrease of -24.58% compared to the previous quarter, and a decrease of -55.52% compared to the same quarter a year before.

CORT Previous Earnings Date & Report Recap: Dec 2020 (FY)

Corcept Therapeutics Incorporated's previous annual earnings date was Feb 8, 2021 for its fiscal year ended Dec 31, 2020.

CORT's earnings per share (EPS) was $0.85, beating the consensus analysts forecast of $0.84 by 1.19% , and higher than the previous year's EPS (Dec 2019) by 8.97%.

Revenues were $353.87M, worse than the forecast of $355.92M by -0.57%, and up by 15.46% from previous year's revenue.

The company reported a net income of $106.01M, 12.56% higher than the previous year.

Corcept Therapeutics Incorporated reported a free cash flow of $150.73M for its fiscal year, compared to $135.03M a year ago.

The company ended the fiscal year with $2.55M in total debt, a decrease of -26.29% compared to the previous year.